JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$438M |
| 3 |
Royal Caribbean
RCL
|
+$434M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$432M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$424M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.08B |
| 2 |
Meta Platforms (Facebook)
META
|
+$722M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$721M |
| 4 |
Apple
AAPL
|
+$701M |
| 5 |
Netflix
NFLX
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.51% |
| 2 | Financials | 13.49% |
| 3 | Technology | 11.69% |
| 4 | Healthcare | 10.22% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2801
CALL
Innoviva
INVA
$1.5B
| $1.26M | ﹤0.01% |
+100,000
| New | +$1.1M |
2016 Q1
0 quarters
|
|
2802
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.34B
| $1.26M | ﹤0.01% |
30,919
-1,063
| -3% | -$39.8K |
2013 Q4
9 quarters
|
|
2803
Village Super Market
VLGEA
$647M
| $1.25M | ﹤0.01% |
51,956
+656
| +1% | +$16.2K |
2015 Q2
3 quarters
|
|
2804
ImmunityBio
IBRX
$10.3B
| $1.25M | ﹤0.01% |
152,196
+3,309
| +2% | +$31.2K |
2015 Q3
2 quarters
|
|
|
VTAE
2805
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $1.25M | ﹤0.01% |
188,800
-14,829
| -7% | -$135K |
2014 Q3
6 quarters
|
|
|
MFRM
2806
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
| $1.25M | ﹤0.01% |
29,500
+29,434
| +44,597% | +$1.2M |
2015 Q4
1 quarter
|
|
|
BKCC
2807
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $1.25M | ﹤0.01% |
132,608
+123,571
| +1,367% | +$1.1M |
2015 Q4
1 quarter
|
|
2808
PTC Therapeutics
PTCT
$5.32B
| $1.25M | ﹤0.01% |
193,539
-16,387
| -8% | -$284K |
2014 Q3
6 quarters
|
|
|
BECN
2809
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $1.24M | ﹤0.01% |
30,350
-53
| -0.2% | -$2.02K |
2013 Q2
11 quarters
|
|
2810
Cal-Maine
CALM
$2.96B
| $1.24M | ﹤0.01% |
23,941
-22,138
| -48% | -$1.1M |
2013 Q2
11 quarters
|
|
2811
IAMGOLD
IAG
$10.6B
| $1.24M | ﹤0.01% |
560,427
+488,151
| +675% | +$950K |
2015 Q4
1 quarter
|
|
2812
Teladoc Health
TDOC
$1.05B
| $1.24M | ﹤0.01% |
129,059
+39,284
| +44% | +$558K |
2015 Q3
2 quarters
|
|
2813
Glaukos
GKOS
$9.53B
| $1.24M | ﹤0.01% |
+73,246
| New | +$1.27M |
2016 Q1
0 quarters
|
|
|
FOMX
2814
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.23M | ﹤0.01% |
188,925
-17,075
| -8% | -$110K |
2015 Q4
1 quarter
|
|
|
CUNB
2815
DELISTED
CU Bancorp
CUNB
| $1.23M | ﹤0.01% |
58,151
+57,943
| +27,857% | +$1.29M |
2015 Q4
1 quarter
|
|
|
VRNT
2816
DELISTED
Verint Systems
VRNT
| $1.23M | ﹤0.01% |
72,209
-143,670
| -67% | -$2.62M |
2013 Q2
11 quarters
|
|
2817
NMI Holdings
NMIH
$3B
| $1.23M | ﹤0.01% |
242,750
+24,712
| +11% | +$129K |
2013 Q4
9 quarters
|
|
2818
Commault Systems
CVLT
$6.42B
| $1.22M | ﹤0.01% |
28,319
-2,803
| -9% | -$104K |
2013 Q2
11 quarters
|
|
|
EQC.PRE
2819
DELISTED
EQUITY COMWLTH CUM RED PFD SR E 7.25% (MD)
EQC.PRE
| $1.22M | ﹤0.01% |
48,050
| – | – |
2014 Q3
6 quarters
|
|
2820
Kennametal
KMT
$2.55B
| $1.21M | ﹤0.01% |
54,003
-5,139
| -9% | -$99.8K |
2013 Q2
11 quarters
|
|
2821
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.18B
| $1.21M | ﹤0.01% |
13,076
+1,899
| +17% | +$166K |
2015 Q4
1 quarter
|
|
2822
PUT
MannKind Corp
MNKD
$1.19B
| $1.21M | ﹤0.01% |
+150,000
| New | +$857K |
2016 Q1
0 quarters
|
|
2823
HNI Corp
HNI
$3.37B
| $1.21M | ﹤0.01% |
30,817
-15,685
| -34% | -$534K |
2013 Q2
11 quarters
|
|
|
ALPN
2824
DELISTED
Alpine Immune Sciences Inc
ALPN
| $1.21M | ﹤0.01% |
72,349
-1,201
| -2% | -$24K |
2015 Q2
3 quarters
|
|
|
CHMA
2825
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $1.21M | ﹤0.01% |
131,825
-1,650
| -1% | -$17.9K |
2015 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2016 Portfolio in Review
As of Q1 2016, JP Morgan Chase held 5,307 positions worth $391B, down 1.9% from $398B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2016 filing shows 536 new, 1,742 increased, 1,913 reduced and 585 closed positions. Its largest new stake was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $1.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 20% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2016 buy was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2016, an estimated $2.23B increase.
- JP Morgan Chase's biggest Q1 2016 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $1.08B.
- JP Morgan Chase fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $721M.
- JP Morgan Chase's ten largest holdings make up 17% of its $391B portfolio in Q1 2016.
- JP Morgan Chase opened 536 new positions and closed 585 in Q1 2016.
- JP Morgan Chase's portfolio value fell 1.9% quarter-over-quarter to $391B.
Based on JP Morgan Chase's 13F filing for Q1 2016, filed 10 May 2016.